financetom
Business
financetom
/
Business
/
Abercrombie & Fitch Fiscal Q3 Adjusted Net Income Falls, Sales Rise; Full-Year Guidance Narrowed
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Abercrombie & Fitch Fiscal Q3 Adjusted Net Income Falls, Sales Rise; Full-Year Guidance Narrowed
Nov 25, 2025 5:29 AM

08:07 AM EST, 11/25/2025 (MT Newswires) -- Abercrombie & Fitch ( ANF ) reported fiscal Q3 adjusted net income Tuesday of $2.36 per diluted share, down from $2.47 a year earlier.

Analysts polled by FactSet expected $2.17.

Net sales for the quarter ended Nov. 1 were $1.29 billion, compared with $1.21 billion a year earlier.

Analysts surveyed by FactSet expected $1.28 billion.

For fiscal Q4, the company expects net income in the range of $3.40 to $3.70 per diluted share. Four analysts polled by FactSet expect $3.50. Fiscal Q4 net sales growth is projected in the range of 4% to 6%. Analysts surveyed by FactSet expect $1.67 billion.

For the full year, Abercrombie & Fitch ( ANF ) now anticipates net income in the range of $10.20 to $10.50 per diluted share, compared with its prior outlook of $10 to $10.50. Four analysts polled by FactSet expect $9.81.

The company now expects full-year net sales growth of 6% to 7%, compared with 5% to 7% growth previously. Analysts surveyed by FactSet expect $5.25 billion.

Shares of the company were up more than 18% in recent Tuesday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Novo Nordisk Seeks FDA Approval for Denecimig to Treat Hemophilia A
Novo Nordisk Seeks FDA Approval for Denecimig to Treat Hemophilia A
Sep 29, 2025
09:21 AM EDT, 09/29/2025 (MT Newswires) -- Novo Nordisk ( NVO ) said Monday it has submitted a biologics license application to the US Food and Drug Administration for Mim8, or denecimig, to treat patients with hemophilia A. The company said Mim8 would come in a single-use, prefilled disposable pen injector with dosing options of once monthly, once every two...
AbbVie to launch ovarian cancer drug in UK at US price
AbbVie to launch ovarian cancer drug in UK at US price
Sep 29, 2025
(Reuters) -AbbVie ( ABBV ) said on Monday it would launch its ovarian cancer drug Elahere in the UK at a list price matching that in the U.S. President Donald Trump has been demanding that drugmakers align domestic prices with the lowest levels paid by comparable high-income countries under the most-favored-nation policy. The U.S. pays nearly three times more for...
Heico Says Eric, Victor Mendelson to Become Co-Chairmen After Death of Father
Heico Says Eric, Victor Mendelson to Become Co-Chairmen After Death of Father
Sep 29, 2025
09:21 AM EDT, 09/29/2025 (MT Newswires) -- Heico ( HEI ) said Monday that Eric and Victor Mendelson were named co-chairmen following the death of their father, executive chairman Laurans Mendelson, on Sept. 27. The aerospace and electronics company said that Eric and Victor Mendelson will remain co-chief executive officers. The company said no changes to business or operations are...
Carnival boosts annual profit forecast on cruise demand
Carnival boosts annual profit forecast on cruise demand
Sep 29, 2025
Sept 29 (Reuters) - Carnival Corp ( CCL ) raised its annual forecast for profit, betting on strong demand and higher onboard spending as well as ticket pricing for its cruise vacations. The company forecast fiscal 2025 adjusted earnings per share of about $2.14, up from its prior expectations of about $1.97. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved